| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |